Rethinking Meningioma Biology: Integrating Molecular and Microenvironmental Insights for Mechanism-Guided Therapy

Meningiomas are the most common primary intracranial tumors, accounting for 42.6% of all central nervous system tumors. Although many meningiomas are indolent, clinical behavior is highly heterogeneous, with recurrence occurring in a minority of low-risk tumors but in more than half of clinically high-risk cases despite standard therapy. During the past decade, significant advancements in molecular profiling have provided insights into meningioma biology and have begun to influence clinical practice. Genomic sequencing, DNA methylation profiling, and gene expression analyses have revealed distinct molecular subgroups with prognostic and therapeutic implications. These advancements, coupled with a growing understanding of the meningioma immune microenvironment, have expanded therapeutic possibilities beyond traditional surgery and radiation approaches. Here, we review how molecular profiling is refining patient stratification and treatment selection, examine the evidence supporting various therapeutic approaches, and explore ongoing clinical trials. Finally, we highlight the critical challenges in advancing personalized medicine for meningioma patients. This comprehensive review provides an integrated overview of current diagnostic and treatment paradigms while offering perspectives on future directions in meningioma therapy.

Authors

Institutions

Publication Details

Journal
Annual Review of Medicine
Published
2026-11-13
DOI
https://doi.org/10.1146/annurev-med-061826-092908
Primary Topic
Meningioma and schwannoma management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Rethinking Meningioma Biology: Integrating Molecular and Microenvironmental Insights for Mechanism-Guided Therapy

David Ronan Raleigh, Mark W. Youngblood, Stephen T. Magill, Pouya Jamshidi et al.
4 links
Annual Review of Medicine
Meningioma and schwannoma management
article

Rethinking Meningioma Biology: Integrating Molecular and Microenvironmental Insights for Mechanism-Guided Therapy

David Ronan Raleigh, Mark W. Youngblood, Stephen T. Magill, Pouya Jamshidi, Amy B. Heimberger, Maciej S. Lesniak, Constantinos G. Hadjipanayis, Chris Z Wei, Jheremy Sebastian Reyes
article en

Abstract

Meningiomas are the most common primary intracranial tumors, accounting for 42.6% of all central nervous system tumors. Although many meningiomas are indolent, clinical behavior is highly heterogeneous, with recurrence occurring in a minority of low-risk tumors but in more than half of clinically high-risk cases despite standard therapy. During the past decade, significant advancements in molecular profiling have provided insights into meningioma biology and have begun to influence clinical practice. Genomic sequencing, DNA methylation profiling, and gene expression analyses have revealed distinct molecular subgroups with prognostic and therapeutic implications. These advancements, coupled with a growing understanding of the meningioma immune microenvironment, have expanded therapeutic possibilities beyond traditional surgery and radiation approaches. Here, we review how molecular profiling is refining patient stratification and treatment selection, examine the evidence supporting various therapeutic approaches, and explore ongoing clinical trials. Finally, we highlight the critical challenges in advancing personalized medicine for meningioma patients. This comprehensive review provides an integrated overview of current diagnostic and treatment paradigms while offering perspectives on future directions in meningioma therapy.

Annual Review of Medicine
Northwestern University (US), University of Pittsburgh (US), University of California, San Francisco (US), University of Pittsburgh Medical Center (US), Robert H. Lurie Comprehensive Cancer Center of Northwestern University (US)
Good health and well-being
Meningioma and schwannoma management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon